Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Capital Medical University: Clinical Trials & FDA Approval Profile

Capital Medical University (Global / Institutional) sponsors 47 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 18 active protocols (8 recruiting now), 10 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)8.5%
Median Closed Enrollment vs National (145 pts)164 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Capital Medical University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)47
Active Pipeline (Recruiting Now)18 (8)
Completed vs Stopped Early10 / 4 (8.5%)
Median Closed Actual Enrollment164 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Capital Medical University
Hospital Research SiteLocationShared Protocols
Xuanwu Hospital Capital Medical UniversityBeijing, Beijing Municipality15
China-Japan Friendship HospitalBeijing, Beijing Municipality6

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Capital Medical University
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06548971Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)Phase IIIRECRUITING
NCT06666764Normobaric Oxygen in AIS Transferred for EVTPhase IIIRECRUITING
NCT06559241Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)Phase IIIRECRUITING
NCT07509645Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation LaPhase IIIRECRUITING
NCT07263308Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2Phase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Capital Medical University Interactive Dossier, benchmark peers in Neurology, Psychiatry, and Pain, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI